The conference is aimed at providing the latest news on EU objectives and current processes as Germany takes the presidency of the EU Council in the second half of 2020.
Experts from the German Health Ministry, industry, HTA bodies and patient associations will discuss issues on supply chains, the optimisation of optimise patient access, the harmonisation of drug assessment in Europe, reimbursement pathways for cell and gene therapies and EU tendering and public procurement trends.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.